• Böck, M., de Haan, J., Beck, K-H., Gutensohn, K., Hertfelder, H-J., Karger, R., Heim, M.U., Beeser, H., Weber, D. & Kretschmer, V. (1999) Standardization of the PFA-100® platelet function test in 105 mmol/l buffered citrate: effect of gender, smoking and oral contraceptives. British Journal of Haematology, 106, 898904.
  • Davi, G., Guagnano, M.T., Ciabattoni, G., Basili, S., Falco, A., Marinopiccoli, M., Nutini, M., Sensi, S. & Patrono, C. (2003) Platelet activation in obese women: role of inflammation and oxidant stress. Journal of the American Medical Association, 289, 17811782.
  • Haubelt, H., Anders, C., Vogt, A., Hoerdt, P., Seyfert, U.T. & Hellstern, P. (2005). Variables influencing PFA-100 closure times in healthy individuals. British Journal of Haematology, 130, 759767.
  • Koscielny, J., Ziemer, S., Radtke, H., Schmutzler, M., Pruss, A., Sinha, P., Salama, A., Kiesewetter, H. & Latza, R. (2004) A practical concept for preoperative identification of patients with impaired primary hemostasis. Clinical and Applied Thrombosis/Haemostasis, 10, 195204.
  • Mamiya, S., Hagiwara, M., Inoue, S. & Hidaka, H. (1989) Thyroid hormones inhibit platelet function and myosin light chain kinase. Journal of Biological Chemistry, 264, 85758579.
  • Mammen, E.F., Comp, P.C., Gosselin, R., Greenberg, C., Hoots, W.K., Kessler, C.M., Larkin, E.C., Liles, D. & Nugent, D.J. (1998) PFA-100 system: a new method for assessment of platelet dysfunction. Seminars in Thrombosis and Hemostasis, 24, 195202.
  • von Beckerath, N., Koch, W., Mehilli, J., Gorchakova, O., Braun, S., Schomig, A. & Kastrati, A. (2004) ABO locus O1 allele and risk of myocardial infarction. Blood Coagulation and Fibrinolysis, 15, 6167.